Listar INIBIC-ECAPE - Artigos por autor "Cequier, Ángel"

Mostrando ítems 1-7 de 7

    • Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry 

      Bertomeu-González, Vicente; Moreno-Arribas, José; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Raña-Míguez, Paula; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory; Marín, Francisco (NLM, 2019-12-24)
      [Abstract] Background. Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ...

    • Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study 

      Moreno-Arribas, José; Bertomeu-González, Vicente; Anguita, Manuel; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (SAGE, 2015-07-30)
      [Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ...

    • Do physicians correctly calculate thromboembolic risk scores?: a comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores 

      Esteve-Pastor, María Asunción; Marín, Francisco; Bertomeu-Martínez, Vicente; Roldán, Inmaculada; Cequier, Ángel; Badimón, Lina; Muñiz, Javier; Valdés, Mariano; Anguita, Manuel (Wiley, 2016-03-01)
      [Abstract] BACKGROUND: Clinical risk scores, CHADS2 and CHA2 DS2 -VASc scores, are the established tools for assessing stroke risk in patients with atrial fibrillation (AF). AIM: The aim of this study is to assess concordance ...

    • La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K 

      Anguita-Sánchez, Manuel; Anguita Gámez, María; Bertomeu, Vicente; Ruiz Ortiz, Martín; Cequier, Ángel; Roldán, Inmaculada; Muñiz, Javier; Esteve-Pastor, María Asunción; Vivas Balcones, David; Marín, Francisco; Pérez-Villascastín, Julián (Elsevier, 2020-07)
      [Resumen] Introducción y objetivos. La fibrilación auricular tiene un mal pronóstico asociado fundamentalmente al desarrollo de ictus. A pesar del uso de anticoagulantes, algunos pacientes pueden sufrir ictus y también ...

    • Quality of anticoagulation with vitamin K antagonists 

      Bertomeu-González, Vicente; Anguita, Manuel; Moreno-Arribas, José; Cequier, Ángel; Muñiz, Javier; Castillo-Castillo, Jesús; Sanchis, Juan; Roldán, Inmaculada; Marín, Francisco; Bertomeu-Martínez, Vicente (Wiley, 2015-05-11)
      [Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ...

    • Relationship of Adverse Events to Quality of Anticoagulation Control in Atrial Fibrillation Patients With Diabetes: Real-World Data From the FANTASIIA Registry 

      García-Fernández, Amaya; Esteve-Pastor, María Asunción; Roldán Rabadán, Inmaculada; Muñiz, Javier; Ruiz Ortiz, Martín; Cequier, Ángel; Bertomeu- Martínez, Vicente; Badimón, Lina; Otero, Déborah; Anguita, Manuel; Lip, Gregory; Marín, Francisco (Taylor & Francis Group, 2020-06-17)
      [Abstract] Background: Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. Purpose: To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF ...

    • Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation 

      Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)
      [Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...